BSE Live
Oct 01, 16:01Prev. Close
1594.95
Open Price
1606.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:59Prev. Close
1594.30
Open Price
1611.90
Bid Price (Qty.)
1636.20 (60)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 22,625.88 | 19,843.53 | 20,394.63 | 15,518.50 | 12,570.93 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 22,625.88 | 19,843.53 | 20,394.63 | 15,518.50 | 12,570.93 | |
Total Operating Revenues | 23,003.33 | 20,275.17 | 20,812.14 | 15,585.98 | 12,803.21 | |
Other Income | 369.43 | 465.76 | 279.03 | 957.92 | 150.22 | |
Total Revenue | 23,372.76 | 20,740.93 | 21,091.17 | 16,543.90 | 12,953.43 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 4,690.67 | 4,429.38 | 5,165.63 | 4,584.97 | 3,809.11 | |
Purchase Of Stock-In Trade | 1,359.53 | 994.41 | 1,126.46 | 1,248.60 | 1,199.63 | |
Operating And Direct Expenses | 0.00 | 344.45 | 313.75 | 275.23 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -69.17 | 180.32 | -237.93 | -183.18 | -214.84 | |
Employee Benefit Expenses | 2,608.26 | 2,373.95 | 2,156.95 | 2,000.78 | 1,798.45 | |
Finance Costs | 893.21 | 784.08 | 472.18 | 388.10 | 256.98 | |
Depreciation And Amortisation Expenses | 1,238.27 | 1,600.62 | 1,600.87 | 1,349.95 | 586.81 | |
Other Expenses | 7,621.42 | 6,365.05 | 5,814.42 | 4,752.06 | 3,274.86 | |
Total Expenses | 18,342.19 | 17,072.26 | 16,412.33 | 14,416.51 | 10,711.00 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5,030.57 | 3,668.67 | 4,678.84 | 2,127.39 | 2,242.43 | |
Exceptional Items | 0.00 | -219.02 | -2,937.79 | -1,820.53 | -89.56 | |
Profit/Loss Before Tax | 5,030.57 | 3,449.65 | 1,741.05 | 306.86 | 2,152.87 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 908.62 | 546.10 | 752.77 | -553.58 | 244.91 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -160.67 | 45.37 | -702.44 | 960.43 | -231.74 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 747.95 | 591.47 | 50.33 | 406.85 | 13.17 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 4,282.62 | 2,858.18 | 1,690.72 | -99.99 | 2,139.70 | |
Profit/Loss From Continuing Operations | 4,282.62 | 2,858.18 | 1,690.72 | -99.99 | 2,139.70 | |
Profit/Loss For The Period | 4,282.62 | 2,858.18 | 1,690.72 | -99.99 | 2,139.70 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 17.80 | 11.90 | 7.00 | -0.40 | 8.92 | |
Diluted EPS (Rs.) | 17.80 | 11.90 | 7.00 | -0.40 | 8.92 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 3,613.97 | 2,898.16 | 2,519.30 | 2,158.91 | 1,559.06 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 1,600.00 | 1,350.00 | 1,150.00 | 1,000.00 | 750.00 |
10.09.2025
07.08.2025
04.08.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875: Prabhudas Lilladher
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend
01.02.2025
Sun Pharma Consolidated December 2024 Net Sales at Rs 13,675.46 crore, up 10.46% Y-o-Y